<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01779739</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00037135</org_study_id>
    <nct_id>NCT01779739</nct_id>
    <nct_alias>NCT03333811</nct_alias>
  </id_info>
  <brief_title>Evaluating Sexual Function After Vaginal Repair With Perineorrhaphy</brief_title>
  <acronym>FaVR</acronym>
  <official_title>Evaluating Sexual Function After Vaginal Repair With Perineorrhaphy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single center, double-blind, randomized controlled trial evaluating the change in
      sexual function in women undergoing vaginal repair for pelvic organ prolapse. Participants
      will be sexually active women who agree to randomization to having perineorrhaphy added to or
      excluded from their surgical repair. We hypothesize that sexual function will improve more
      significantly in women undergoing vaginal repair with perineorrhaphy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in sexual function as measured by validated questionnaire</measure>
    <time_frame>6 months and 12 months after surgery</time_frame>
    <description>Validated questionnaires will be administered prior to surgery, as well as at intervals after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prolapse recurrence</measure>
    <time_frame>6 months, 12 months</time_frame>
    <description>A composite outcome score to define success of prolapse surgery will be applied to subjects at 6 and 12 months specifically looking for return of prolapse symptoms, anatomic recurrence, and need for retreatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Sexual Function</condition>
  <arm_group>
    <arm_group_label>No perineorrhaphy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will not have a perineorrhaphy procedure added to the vaginal prolapse repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Perineorrhaphy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will have a perineorrhaphy added to the vaginal repair of prolapse</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Perineorrhaphy</intervention_name>
    <description>Procedure to build up the vaginal opening</description>
    <arm_group_label>Perineorrhaphy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  sexually active

          -  genital hiatus measured between 4 and 6 centimeters

          -  desires sexual function

          -  undergoing vaginal repair with native tissues

          -  agrees to use vaginal estrogen for 12 months after surgery

        Exclusion Criteria:

          -  genital hiatus &gt; 6 cm

          -  planned obliterative procedure

          -  perineal body length &lt;0.5cm

          -  disrupted external anal sphincter
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>105 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Candace Y Parker-Autry, MD</last_name>
    <role>Study Director</role>
    <affiliation>Wake Forest</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Holly E Richter, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2013</study_first_submitted>
  <study_first_submitted_qc>January 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2013</study_first_posted>
  <last_update_submitted>February 21, 2018</last_update_submitted>
  <last_update_submitted_qc>February 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vaginal prolapse</keyword>
  <keyword>sexual function</keyword>
  <keyword>sexual dysfunction</keyword>
  <keyword>prolapse surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

